Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2010
11/25/2010WO2010114628A9 Formulation for inducing broadly reactive neutralizing anti-hiv antibodies
11/25/2010WO2010095940A3 Glutathione-based drug delivery system
11/25/2010WO2010085128A3 Processes for preparing hiv reverse transcriptase inhibitors
11/25/2010WO2010085091A3 Pharmaceutical composition for preventing or treating hepatitis c, comprising the roots extract of platycodon grandiflorum or platycodon grandiflorum saponin components
11/25/2010WO2010081082A3 Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
11/25/2010WO2010003533A3 Pyridopyrimidine compounds as anti-tubercular agents
11/25/2010WO2009142842A9 Novel macrocyclic inhibitors of hepatitis c virus replication
11/25/2010WO2009131548A8 Multimeric forms of antimicrobial peptides
11/25/2010US20100298447 Composite product of low-solubility drug and surfactant, and process for production thereof
11/25/2010US20100298423 Nutraceutical composition from garcinia mangostana
11/25/2010US20100298419 Antibiotic-free plasmid
11/25/2010US20100298418 Assay for measuring plasma FGL-2 and methods and uses thereof
11/25/2010US20100298414 Development of a preventive vaccine for filovirus infection in primates
11/25/2010US20100298408 Oligonucleotide Compositions with Enhanced Efficiency
11/25/2010US20100298402 Stilbene derivatives as pstat3/il-6 inhibitors
11/25/2010US20100298390 Inhibition of lethal factor protease activity from anthrax toxin
11/25/2010US20100298388 Substituted benamidines as antibacterial agents
11/25/2010US20100298386 Compositions and methods for treating mastitis
11/25/2010US20100298384 Novel oxazolidinone compounds as antiinfective agents
11/25/2010US20100298383 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
11/25/2010US20100298374 Nitrile derivatives and their pharmaceutical use and compositions
11/25/2010US20100298370 Benzothiazolyl thienopyridine derivatives and uses thereof
11/25/2010US20100298366 Chemokine receptor binding compounds
11/25/2010US20100298364 salts 756
11/25/2010US20100298355 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
11/25/2010US20100298354 Crystalline Form Of Abacavir That Is Essentially Free Of Solvent
11/25/2010US20100298353 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
11/25/2010US20100298326 Carboxamide compounds and their use as calpain inhibitors
11/25/2010US20100298312 Substituted pyrimidinyl-amines as protein kinase inhibitors
11/25/2010US20100298302 Novel protein kinase modulators
11/25/2010US20100298295 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
11/25/2010US20100298289 Heterobicyclic compounds as histamine h4-receptor antagonists
11/25/2010US20100298257 Nucleoside phosphoramidates
11/25/2010US20100298256 Antiviral compounds
11/25/2010US20100298252 Methods and compositions for ophthalmic treatment of fungal and bacterial infections
11/25/2010US20100298250 Compositions and methods for extracting and using phytochemicals for the treatment of influenza
11/25/2010US20100298245 Pharmaceutical Composition for the Treatment of IL-8 mediated diseases
11/25/2010US20100298238 Nontoxic shiga-like toxin mutant compositions and methods
11/25/2010US20100298236 Soluble gp130 muteins with improved binding activity
11/25/2010US20100298231 Pmma binding peptides
11/25/2010US20100298216 Casein Derived Peptides And Uses Thereof in Therapy
11/25/2010US20100298210 HCV NS3 Protease Inhibitors
11/25/2010US20100298209 Compounds for preventing or treating a viral infection
11/25/2010US20100298208 Biofilm prevention using lactoferrin
11/25/2010US20100298206 Hybrid oligomers, their preparation process and pharmaceutical compositions containing them
11/25/2010US20100298200 Compounds and assays for controlling Wnt activity
11/25/2010US20100298164 Structure-based approach to design of inhibitors of protein-processivity factor interactions
11/25/2010US20100297269 Compositions for intranasal administration
11/25/2010US20100297256 Methods and compositions for inhibiting integrins using tellurium-containing compounds
11/25/2010US20100297255 Malleable implants containing demineralized bone matrix
11/25/2010US20100297243 Prion free nanoparticle compositions and methods of making thereof
11/25/2010US20100297236 Hybrid inducible release vehicle
11/25/2010US20100297231 Preservation of bioactive materials by freeze dried foam
11/25/2010US20100297221 pharmaceutical composition of tacrolimus
11/25/2010US20100297209 Solvent/polymer solutions as suspension vehicles
11/25/2010US20100297205 Patch for the expulsion of insect poison from the skin after stings from membranous insects (hymenoptera)
11/25/2010US20100297200 Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
11/25/2010US20100297192 Use of microparticles for vaccines and the release of biologically active molecules
11/25/2010US20100297186 Multicomponent or monocomponent vaccine to be used against chagas disease, pharmaceutical compositions containing them, procedure for the obtention of immunogen of said vaccines, and nucleic acid used in said procedure
11/25/2010US20100297184 Vaccines
11/25/2010US20100297183 Immunogenic streptococcus proteins
11/25/2010US20100297180 Botulinum neurotoxin vaccine
11/25/2010US20100297179 Immunology Treatment for Biofilms
11/25/2010US20100297174 Influenza virus vaccines and uses thereof
11/25/2010US20100297172 Replication-defective arenavirus vectors
11/25/2010US20100297171 Development of a preventive vaccine for filovirus infection in primates
11/25/2010US20100297170 Vaccines
11/25/2010US20100297169 Novel Neutralizing Immunogen (NIMIV) of Rhinovirus and its Use for Vaccine Applications
11/25/2010US20100297168 Lentiviral gene transfer vectors and their medicinal applications
11/25/2010US20100297167 Method for the Production of Recombinant Virus, DNA Constructs, Recombinant Virus and Vaccine Compositions
11/25/2010US20100297166 Meningococcal Oligosaccharide Linked Polysaccharides and Diptheria Protein Conjucate Vaccine for All Ages
11/25/2010US20100297165 Immunostimulatory combinations of tlr ligands and methods of use
11/25/2010US20100297162 S. epidermidis antigens
11/25/2010US20100297156 Analogues of phosphatidylinositol mannosides
11/25/2010US20100297149 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
11/25/2010US20100297144 Multitype hpv peptide compositions and methods for treatment or prevention of human papillomavirus infection
11/25/2010US20100297141 Anti-adhesin based passive immunoprophlactic
11/25/2010US20100297139 Methods and compositions for the treatment of proteinuric diseases
11/25/2010US20100297133 Immunogenic Polypeptides and Monoclonal Antibodies
11/25/2010US20100297130 Protective anti-glucan antibodies with preference for beta-1,3-glucans
11/25/2010US20100297126 Monoclonal Antibodies Specific to Hemagglutinin from Influenza Virus H5-Subtype and Uses Thereof
11/25/2010US20100297124 Induced internalization of surface receptors
11/25/2010US20100297114 Antigen presenting cell targeted vaccines
11/25/2010US20100297109 Methods for inhibiting fascin
11/25/2010US20100297092 Inactivated Bacterial Cell Formulation
11/25/2010US20100297086 Bacteriophage preparations and methods of use thereof
11/25/2010US20100297081 Pharmaceutical formulation containing recombinant human serum albumin-interferon alpha fusion protein
11/25/2010US20100297080 Genetic markers associated with interferon-alpha response
11/25/2010US20100297079 Compounds, compositions and methods for treating viral infection
11/25/2010US20100297078 Method for producing a hydroxyalkyl starch derivative with two linkers
11/25/2010US20100297073 Heterocyclic antiviral compounds
11/25/2010US20100297068 Methods for treating viral infection using il-28 and il-29
11/25/2010US20100297066 Biodegradable peptide releasing polymers
11/25/2010US20100297061 Stat3 antagonists and their uses as vaccines against cancer
11/25/2010US20100297058 Prebiotic composition
11/25/2010US20100297031 Orodispersible tablets
11/25/2010US20100297029 Virucidal composition
11/25/2010US20100297028 Medicament combinations for the treatment of respiratory diseases
11/25/2010CA2819700A1 N- [(2'r) -2'-deoxy-2'-fluoro-2' -methyl-p-phenyl-5' -uridylyl] -l-alanine 1-methylethyl ester and process for its production
11/25/2010CA2799711A1 Extended acting oxygen generating composition for treating microbial infections
1 ... 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 ... 1798